Literature DB >> 10735275

Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2).

D J Duggan1, D Manchester, K P Stears, D J Mathews, C Hart, E P Hoffman.   

Abstract

The dystrophin-based membrane cytoskeleton of muscle fibers has emerged as a critical multi-protein complex which seems to impart structural integrity on the muscle fiber plasma membrane. Deficiency of dystrophin causes the most common types of muscular dystrophy, Duchenne and Becker muscular dystrophies. Muscular dystrophy patients showing normal dystrophin protein and gene analysis are generally isolated cases with a presumed autosomal recessive inheritance pattern (limb-girdle muscular dystrophy). Recently, linkage and candidate gene analyses have shown that some cases of limb-girdle muscular dystrophy can be caused by deficiency of other components of the dystrophin membrane cytoskeleton. The most recently identified component, delta-sarcoglycan, has been found to show mutations in a series of Brazilian muscular dystrophy patients. All patients were homozygous for a protein-truncating carboxy-terminal mutation, and showed a deficiency of the four sarcoglycan proteins. To determine if delta-sarcoglycan deficiency occurred in other world populations, to identify the range of mutations and clinical phenotypes, and to test for the biochemical consequences of delta-sarcoglycan gene mutations, we studied Duchenne-like and limb-girdle muscular dystrophy patients who we had previously shown not to exhibit gene mutations of dystrophin, alpha-, beta-, or gamma-sarcoglycan for delta-sarcoglycan mutations (n = 54). We identified two American patients with novel nonsense mutations of delta-sarcoglycan (W30X, R165X). One was apparently homozygous, and we show likely consanguinity through homozygosity for 13 microsatellite loci covering a 38 cM region of chromosome 5. The second was heterozygous. Both were girls who showed clinical symptoms consistent with Duchenne muscular dystrophy in males. Our data shows that delta-sarcoglycan deficiency occurs in other world populations, and that most or all patients show a deficiency of the entire sarcoglycan complex, adding support to the hypothesis that these proteins function as a tetrameric unit.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10735275     DOI: 10.1007/s100480050008

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  16 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Muscle biopsy.

Authors:  G Meola; E Bugiardini; R Cardani
Journal:  J Neurol       Date:  2011-07-30       Impact factor: 4.849

3.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.

Authors:  S Tsubata; K R Bowles; M Vatta; C Zintz; J Titus; L Muhonen; N E Bowles; J A Towbin
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  A new evidence for the maintenance of the sarcoglycan complex in muscle sarcolemma in spite of the primary absence of delta-SG protein.

Authors:  Telma L F Gouveia; Patrícia M Kossugue; Julia F Paim; Mayana Zatz; Louise V B Anderson; Vincenzo Nigro; Mariz Vainzof
Journal:  J Mol Med (Berl)       Date:  2007-01-30       Impact factor: 4.599

5.  Dystrophin-compromised sarcoglycan-δ-knockout diaphragm requires full wild-type embryonic stem cell reconstitution for correction.

Authors:  Joseph M Vitale; Joel S Schneider; Amanda J Beck; Qingshi Zhao; Corey Chang; Richard Gordan; Jennifer Michaels; Mantu Bhaumik; Diego Fraidenraich
Journal:  J Cell Sci       Date:  2012-02-10       Impact factor: 5.285

6.  A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardiomyopathy.

Authors:  Satu Kärkkäinen; Raija Miettinen; Petri Tuomainen; Päivi Kärkkäinen; Tiina Heliö; Eeva Reissell; Maija Kaartinen; Lauri Toivonen; Markku S Nieminen; Johanna Kuusisto; Markku Laakso; Keijo Peuhkurinen
Journal:  J Mol Med (Berl)       Date:  2003-10-15       Impact factor: 4.599

7.  SERCA2a gene therapy can improve symptomatic heart failure in δ-sarcoglycan-deficient animals.

Authors:  Sophie Bouyon; Véronique Roussel; Yves Fromes
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

8.  A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.

Authors:  Kazuhiro Kobuke; Federica Piccolo; Keith W Garringer; Steven A Moore; Eileen Sweezer; Baoli Yang; Kevin P Campbell
Journal:  Hum Mol Genet       Date:  2008-02-05       Impact factor: 6.150

9.  The sockeye salmon genome, transcriptome, and analyses identifying population defining regions of the genome.

Authors:  Kris A Christensen; Eric B Rondeau; David R Minkley; Dionne Sakhrani; Carlo A Biagi; Anne-Marie Flores; Ruth E Withler; Scott A Pavey; Terry D Beacham; Theresa Godin; Eric B Taylor; Michael A Russello; Robert H Devlin; Ben F Koop
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

10.  A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies.

Authors:  E S Moreira; M Vainzof; S K Marie; V Nigro; M Zatz; M R Passos-Bueno
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.